OnKure Therapeutics, Inc.(OKUR)

Biotechnology · Boulder, CO

$2.46-0.17 (-6.46%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T21:57:44.299Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:57:44.299Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 2.46
Unrounded diluted TTM EPS · period ending 2026-06-30: -3.5

FMP input reference: 352cae2fe5eed9f02885becd1bbca6bb54c51239af0254a5780fc03f1b1dafbc

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

OKUR PE Ratio Metrics

PE RATIO

N/A

OKUR Competitors' PE Ratio

OKUR

OnKure Therapeutics, Inc.

Current

Market Cap

$99.62M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNXU

Conexeu Sciences Inc.

vs OKUR

Market Cap

$97.94M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PYPD

PolyPid Ltd.

vs OKUR

Market Cap

$97.90M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JYNT

The Joint Corp.

vs OKUR

Market Cap

$101.36M

PE Ratio

26.82

TTM Avg

39.41

3Y Avg

48.57

5Y Avg

115.64

KRRO

Korro Bio, Inc.

vs OKUR

Market Cap

$97.14M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ANIX

Anixa Biosciences, Inc.

vs OKUR

Market Cap

$102.75M

PE Ratio

N/A

TTM Avg

597.78

3Y Avg

597.78

5Y Avg

597.78

BDTX

Black Diamond Therapeutics, Inc.

vs OKUR

Market Cap

$103.14M

PE Ratio

N/A

TTM Avg

17.69

3Y Avg

17.69

5Y Avg

17.69

MIST

Milestone Pharmaceuticals Inc.

vs OKUR

Market Cap

$95.14M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Definitive Healthcare Corp.

vs OKUR

Market Cap

$104.26M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLYX

Polaryx Therapeutics, Inc. Common Stock

vs OKUR

Market Cap

$104.68M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
OnKure Therapeutics, Inc. (OKUR)	$99.62M	N/A	N/A	N/A	N/A
Conexeu Sciences Inc. (CNXU)vs ›	$97.94M	N/A	N/A	N/A	N/A
PolyPid Ltd. (PYPD)vs ›	$97.90M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$101.36M	26.82	39.41	48.57	115.64
Korro Bio, Inc. (KRRO)vs ›	$97.14M	N/A	N/A	N/A	N/A
Anixa Biosciences, Inc. (ANIX)vs ›	$102.75M	N/A	597.78	597.78	597.78
Black Diamond Therapeutics, Inc. (BDTX)vs ›	$103.14M	N/A	17.69	17.69	17.69
Milestone Pharmaceuticals Inc. (MIST)vs ›	$95.14M	N/A	N/A	N/A	N/A
Definitive Healthcare Corp. (DH)vs ›	$104.26M	N/A	N/A	N/A	N/A
Polaryx Therapeutics, Inc. Common Stock (PLYX)vs ›	$104.68M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$2.46

Forward EPS (Est.)

$-1.83

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

OKUR PE Ratio Metrics

OKUR Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics